Treatment of o-iodobiphenyls with o-bromobenzyl alcohols in the presence of cesium carbonate under palladium catalysis affords a series of highly substituted triphenylenes. The reaction involves two C-C bond formations and C-C and C-H bond cleavages. A combination of palladium and an electron-deficient phosphine ligand proves to be effective for both decarbonylative cross-coupling and intramolecular cyclization.
o-Bromobenzyl alcohol has been developed as a novel annulating reagent, bearing both nucleophilic and electrophilic substituents, for the facile synthesis of polycyclic aromatic hydrocarbons. A palladium/electron-deficient phosphine catalyst efficiently coupled o-iodobiphenyls or (Z)-β-halostyrenes with o-bromobenzyl alcohols to afford triphenylenes and phenanthrenes, respectively. The present cascade reaction proceeded through deacetonative cross-coupling and sequential intramolecular cyclization. An array of experimental data suggest that the reaction mechanism involves the equilibrium of 1,4-palladium migration.
Complex. -o-Bromobenzyl alcohols are introduced as new annulation reagents, which facilitate the annulation of o-iodobiphenyls and (Z)--halostyrenes to afford triphenylenes and phenanthrenes, respectively. This protocol enables the synthesis of highly fused -conjugated molecules bearing various functional groups. -(IWASAKI, M.; ARAKI, Y.; IINO, S.; NISHIHARA*, Y.; J. Org. Chem. 80 (2015) 18, 9247-9263, http://dx.doi.org/10.
Palladium-Catalyzed Annulation of o-Iodobiphenyls with o-Bromobenzyl Alcohols: Synthesis of Functionalized Triphenylenes via C-C and C-H BondCleavages. -(IWASAKI, M.; IINO, S.; NISHIHARA*, Y.; Org. Lett. 15 (2013) 20, 5326-5329, http://dx.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.